Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2011

View Archived Issues

StemCells begins phase I/II neural stem cell trial in spinal cord injury

Tumor-targeted nonclustered nanoparticles effective as MRI probes

Iron chelator M-30 may be beneficial in amyotrophic lateral sclerosis

ACADIA Pharmaceuticals presents new muscarinic acetylcholine receptor agonists

Start-up biotech company ImmusanT focuses on celiac disease immunotherapy

Novel HIV integrase inhibitors patented by Merck & Co.

Biodel selects two ultrarapid-acting insulin formulations for clinical development

Novel series of protein kinase inhibitors presented by Merck & Co.

Novel tyrosine-protein kinase BTK inhibitors presented by Bristol-Myers Squibb

University of Virginia presents new sphingosine kinase inhibitors

Anavex Life Sciences cleared to conduct phase I ANAVEX 2-73 study in Germany

Seattle Genetics and Millennium extend antibody-drug conjugate agreement

Safety and tolerability of GT-MAb 2.5-GEX seen in phase I trial in advanced/metastatic cancer

Daiichi Sankyo postpones Japanese launch of Memary tablets for Alzheimer's due to earthquake

Unigene begins dosing in phase II study of oral parathyroid hormone for osteoporosis

Boehringer Ingelheim obtains rights to Acuform technology and Glumetza data

Pluristem Therapeutics and NYU Medical Center partner to treat diabetic foot ulcers

Researchers describe protein aggregation inhibitor with potential for neurodegenerative diseases

Vernalis begins dosing patients in phase I trial of pain candidate V-158866

Cleveland Clinic grants Apeiron option to license SHP-1 inhibitors

Chinese health authorities approve Novo Nordisk's Victoza for type 2 diabetes

Agennix completes enrollment of phase III FORTIS-M trial of talactoferrin in NSCLC

In vivo protective effects of carbon nanotubes against ischemic brain injury

Src disruption enhances sensitivity of multiple myeloma cells to Chk1 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...